Work

Therapeutic Anti-Cd3 Monoclonal Antibodies: From Bench to Bedside

Year: 2016
Type: review
Abstract: The induction of tolerance is a major goal of immunotherapy. Investigations over the last 20 years have shown that anti-CD3 monoclonal antibodies (mAbs) effectively treat autoimmune disease in animal models and have also shown promise in clinical trials. Tolerance induction by anti-CD3 mAbs is related to the induction of Tregs that control pathogenic autoimmune responses. Here, we review preclinical and clinical studies in which intravenous or mucosal administration of anti-CD3 mAbs has been employed and provide an outlook on future developments to enhance the efficacy of this promising therapeutic approach.
Language: English
Subfield: Immunology
Open Access status: hybrid
OpenAlex ID: W2379702652
FWCI: 1.691
Cites: 141
Cited by: 220
Related to: 9